JAMA
@jama.com
JAMA is an international peer-reviewed general medical journal and a member of the JAMA Network family of journals.
🌐 JAMA.com
🌐 JAMA.com
Peripheral neuropathy affects approximately 1% of adults worldwide. Author Michelle Mauermann, MD, of the Mayo Clinic, joins JAMA Deputy Editor Mary McDermott, MD, to discuss diagnosis and optimal management.
Listen now: ja.ma/4oTs5YX
Listen now: ja.ma/4oTs5YX
November 22, 2025 at 5:00 PM
Peripheral neuropathy affects approximately 1% of adults worldwide. Author Michelle Mauermann, MD, of the Mayo Clinic, joins JAMA Deputy Editor Mary McDermott, MD, to discuss diagnosis and optimal management.
Listen now: ja.ma/4oTs5YX
Listen now: ja.ma/4oTs5YX
💬 Viewpoint: Strengthening and coordinating civilian-military health partnerships nationwide is essential to protect patients in the event of large-scale armed conflict.
ja.ma/4ifnIoz
ja.ma/4ifnIoz
November 22, 2025 at 4:00 PM
💬 Viewpoint: Strengthening and coordinating civilian-military health partnerships nationwide is essential to protect patients in the event of large-scale armed conflict.
ja.ma/4ifnIoz
ja.ma/4ifnIoz
✅ Editor’s Choice: This Review summarizes the diagnosis and management of primary malignant #BrainTumors in adults, including glioblastoma, lower-grade gliomas, primary CNS lymphoma, malignant meningiomas, and ependymomas.
Save this for your citations: ja.ma/4prtQwC
Save this for your citations: ja.ma/4prtQwC
November 22, 2025 at 3:00 PM
✅ Editor’s Choice: This Review summarizes the diagnosis and management of primary malignant #BrainTumors in adults, including glioblastoma, lower-grade gliomas, primary CNS lymphoma, malignant meningiomas, and ependymomas.
Save this for your citations: ja.ma/4prtQwC
Save this for your citations: ja.ma/4prtQwC
Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss highlights from #KidneyWk.
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
November 22, 2025 at 2:00 PM
Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss highlights from #KidneyWk.
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
Pathogenic variants in key cancer susceptibility genes were detected in 5% of US adults in the All of Us study, exceeding prior estimates and highlighting race-based differences in prevalence.
ja.ma/47UCKwD
ja.ma/47UCKwD
November 22, 2025 at 1:00 PM
Pathogenic variants in key cancer susceptibility genes were detected in 5% of US adults in the All of Us study, exceeding prior estimates and highlighting race-based differences in prevalence.
ja.ma/47UCKwD
ja.ma/47UCKwD
JAMA Deputy Editors Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, discuss the latest science published in JAMA:
➡️ Lung Cancer Screening Benefits,
➡️ Peripheral Neuropathy Review,
➡️ Arsenic Exposure and Mortality, and more.
ja.ma/3LRQzDy
➡️ Lung Cancer Screening Benefits,
➡️ Peripheral Neuropathy Review,
➡️ Arsenic Exposure and Mortality, and more.
ja.ma/3LRQzDy
November 22, 2025 at 12:00 PM
JAMA Deputy Editors Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, discuss the latest science published in JAMA:
➡️ Lung Cancer Screening Benefits,
➡️ Peripheral Neuropathy Review,
➡️ Arsenic Exposure and Mortality, and more.
ja.ma/3LRQzDy
➡️ Lung Cancer Screening Benefits,
➡️ Peripheral Neuropathy Review,
➡️ Arsenic Exposure and Mortality, and more.
ja.ma/3LRQzDy
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss the launch of the Governors Public Health Alliance, an initiative to bolster disease detection and response amid US federal funding cuts.
Listen now: ja.ma/43EfRes
Listen now: ja.ma/43EfRes
November 21, 2025 at 6:00 PM
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss the launch of the Governors Public Health Alliance, an initiative to bolster disease detection and response amid US federal funding cuts.
Listen now: ja.ma/43EfRes
Listen now: ja.ma/43EfRes
Recent estimates suggest that chronic kidney disease affects nearly 800 million adults worldwide.
In this Q&A, conference cochair Katherine Tuttle, MD, shares clinical research highlights from Kidney Week 2025.
In this Q&A, conference cochair Katherine Tuttle, MD, shares clinical research highlights from Kidney Week 2025.
Kidney Week 2025 Highlights
This Medical News article is an interview with Katherine R. Tuttle, MD, education committee co-chair of Kidney Week 2025 and a professor of medicine at the University of Washington.
jamanetwork.com
November 21, 2025 at 4:30 PM
Recent estimates suggest that chronic kidney disease affects nearly 800 million adults worldwide.
In this Q&A, conference cochair Katherine Tuttle, MD, shares clinical research highlights from Kidney Week 2025.
In this Q&A, conference cochair Katherine Tuttle, MD, shares clinical research highlights from Kidney Week 2025.
Amid federal funding cuts- and often controversial changes in guidance, 15 state and territorial leaders have come together to create the Governor’s Public Health Alliance.
Here’s what to know about the new coalition.
Here’s what to know about the new coalition.
US Governors Launch Multistate Public Health Coalition
This Medical News article discusses a new state-led coalition, called the Governors Public Health Alliance, to bolster disease detection and response as federal support wanes.
jamanetwork.com
November 21, 2025 at 4:26 PM
Amid federal funding cuts- and often controversial changes in guidance, 15 state and territorial leaders have come together to create the Governor’s Public Health Alliance.
Here’s what to know about the new coalition.
Here’s what to know about the new coalition.
In 2024, only 19% of individuals in the US eligible for annual lung cancer screening underwent screening, preventing an estimated 15 000 deaths. Full uptake could prevent 3 times as many deaths. #LungCancer
ja.ma/4ru3ZWL
ja.ma/4ru3ZWL
November 21, 2025 at 3:00 PM
In 2024, only 19% of individuals in the US eligible for annual lung cancer screening underwent screening, preventing an estimated 15 000 deaths. Full uptake could prevent 3 times as many deaths. #LungCancer
ja.ma/4ru3ZWL
ja.ma/4ru3ZWL
US physician Medicare participation rose by 6.3% from 2013 to 2023, but exit rates were higher among female, older, and primary care physicians, especially in rural and shortage areas, with potential impact on access for underserved populations.
ja.ma/4rhmpK8
ja.ma/4rhmpK8
November 21, 2025 at 2:00 PM
US physician Medicare participation rose by 6.3% from 2013 to 2023, but exit rates were higher among female, older, and primary care physicians, especially in rural and shortage areas, with potential impact on access for underserved populations.
ja.ma/4rhmpK8
ja.ma/4rhmpK8
💬 Viewpoint: The evolution of direct-to-consumer pharmaceutical advertising into a public health crisis necessitates urgent FDA action to rectify decades of regulatory laxity, misleading promotion, and undermining of the patient-doctor relationship.
ja.ma/48wmyRt
ja.ma/48wmyRt
November 21, 2025 at 1:00 PM
💬 Viewpoint: The evolution of direct-to-consumer pharmaceutical advertising into a public health crisis necessitates urgent FDA action to rectify decades of regulatory laxity, misleading promotion, and undermining of the patient-doctor relationship.
ja.ma/48wmyRt
ja.ma/48wmyRt
Individual-level reductions in urinary #arsenic, achieved through community mitigation, were associated with lower mortality from chronic diseases, including #cancer and #cardiovascular disease.
ja.ma/43HYY2x
ja.ma/43HYY2x
November 21, 2025 at 12:00 PM
Individual-level reductions in urinary #arsenic, achieved through community mitigation, were associated with lower mortality from chronic diseases, including #cancer and #cardiovascular disease.
ja.ma/43HYY2x
ja.ma/43HYY2x
JAMA+ AI Associate Editor Yulin Hswen talks with Eric Horvitz, MD, PhD, Chief Scientific Officer at Microsoft, about the future of #AI, and how we can guide AI to be copilots while maintaining integrity and safety.
🎧 Listen now: ja.ma/4pgWgcl
🎧 Listen now: ja.ma/4pgWgcl
November 20, 2025 at 5:30 PM
JAMA+ AI Associate Editor Yulin Hswen talks with Eric Horvitz, MD, PhD, Chief Scientific Officer at Microsoft, about the future of #AI, and how we can guide AI to be copilots while maintaining integrity and safety.
🎧 Listen now: ja.ma/4pgWgcl
🎧 Listen now: ja.ma/4pgWgcl
💬 Viewpoint: California AB 455 mandates disclosure of thirdhand smoke contamination in home sales and updates consumer education.
The law expands tobacco control to housing and may reduce exposure risks for vulnerable populations.
ja.ma/4i7x5GS
The law expands tobacco control to housing and may reduce exposure risks for vulnerable populations.
ja.ma/4i7x5GS
November 20, 2025 at 5:00 PM
💬 Viewpoint: California AB 455 mandates disclosure of thirdhand smoke contamination in home sales and updates consumer education.
The law expands tobacco control to housing and may reduce exposure risks for vulnerable populations.
ja.ma/4i7x5GS
The law expands tobacco control to housing and may reduce exposure risks for vulnerable populations.
ja.ma/4i7x5GS
#Osteoporosis is a common disease among older adults that weakens bones and increases the likelihood of fractures.
This JAMA Patient Page describes osteoporosis risk factors, symptoms, screening, diagnosis, and treatment.
ja.ma/4oTfhC2
This JAMA Patient Page describes osteoporosis risk factors, symptoms, screening, diagnosis, and treatment.
ja.ma/4oTfhC2
November 20, 2025 at 4:45 PM
#Osteoporosis is a common disease among older adults that weakens bones and increases the likelihood of fractures.
This JAMA Patient Page describes osteoporosis risk factors, symptoms, screening, diagnosis, and treatment.
ja.ma/4oTfhC2
This JAMA Patient Page describes osteoporosis risk factors, symptoms, screening, diagnosis, and treatment.
ja.ma/4oTfhC2
💬 Editor's Note: How can #AI systems reason safely in the open world of medicine?
JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, discusses the future of #AI with Eric Horvitz, MD, PhD, chief scientific officer at @microsoft.com.
ja.ma/4ik6bvB
JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, discusses the future of #AI with Eric Horvitz, MD, PhD, chief scientific officer at @microsoft.com.
ja.ma/4ik6bvB
November 20, 2025 at 4:15 PM
💬 Editor's Note: How can #AI systems reason safely in the open world of medicine?
JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, discusses the future of #AI with Eric Horvitz, MD, PhD, chief scientific officer at @microsoft.com.
ja.ma/4ik6bvB
JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, discusses the future of #AI with Eric Horvitz, MD, PhD, chief scientific officer at @microsoft.com.
ja.ma/4ik6bvB
Editorial: "Remembering Drummond Rennie—Champion of Integrity in Science and Scientific Publication."
ja.ma/4iae9Y9
ja.ma/4iae9Y9
Remembering Drummond Rennie—Champion of Integrity in Science and Scientific Publication
Drummond Rennie, physician, scientist, editor, climber, tireless promoter of integrity and transparency in science, and mentor to many, died on September 12, 2025, at the age of 89.
ja.ma
November 20, 2025 at 2:00 PM
Editorial: "Remembering Drummond Rennie—Champion of Integrity in Science and Scientific Publication."
ja.ma/4iae9Y9
ja.ma/4iae9Y9
Among patients undergoing transcatheter atrial septal defect closure, a bioresorbable occluder was noninferior to a metallic occluder for 6-month and 2-year closure success and device safety.
ja.ma/4oPW0Bn
ja.ma/4oPW0Bn
November 20, 2025 at 1:00 PM
Among patients undergoing transcatheter atrial septal defect closure, a bioresorbable occluder was noninferior to a metallic occluder for 6-month and 2-year closure success and device safety.
ja.ma/4oPW0Bn
ja.ma/4oPW0Bn
How can transparency and communication help build trust in #AI-driven health care?
Listen to JAMA+ AI EIC Roy Perlis and Associate Editor Yulin Hswen discuss this and more in this special anniversary episode: ja.ma/4pfOJul
Visit JAMA+ AI and learn more: ja.ma/48igsoF
Listen to JAMA+ AI EIC Roy Perlis and Associate Editor Yulin Hswen discuss this and more in this special anniversary episode: ja.ma/4pfOJul
Visit JAMA+ AI and learn more: ja.ma/48igsoF
November 20, 2025 at 12:00 PM
How can transparency and communication help build trust in #AI-driven health care?
Listen to JAMA+ AI EIC Roy Perlis and Associate Editor Yulin Hswen discuss this and more in this special anniversary episode: ja.ma/4pfOJul
Visit JAMA+ AI and learn more: ja.ma/48igsoF
Listen to JAMA+ AI EIC Roy Perlis and Associate Editor Yulin Hswen discuss this and more in this special anniversary episode: ja.ma/4pfOJul
Visit JAMA+ AI and learn more: ja.ma/48igsoF
💬 Viewpoint: The CMS Ambulatory Specialty Model mandates value-based payment for specialists treating costly chronic conditions. However, issues such as risk adjustment limitations, administrative burdens, and potential inequities remain.
ja.ma/48d3QOC
ja.ma/48d3QOC
November 19, 2025 at 5:00 PM
💬 Viewpoint: The CMS Ambulatory Specialty Model mandates value-based payment for specialists treating costly chronic conditions. However, issues such as risk adjustment limitations, administrative burdens, and potential inequities remain.
ja.ma/48d3QOC
ja.ma/48d3QOC
Perinatal #depression affects about 1 in 7 individuals, with symptoms including impaired attachment and risk of suicide.
💡 This JAMA Insights discusses the most effective pharmacological treatments for individuals experiencing perinatal depression.
ja.ma/47YjX3H
💡 This JAMA Insights discusses the most effective pharmacological treatments for individuals experiencing perinatal depression.
ja.ma/47YjX3H
November 19, 2025 at 4:30 PM
Perinatal #depression affects about 1 in 7 individuals, with symptoms including impaired attachment and risk of suicide.
💡 This JAMA Insights discusses the most effective pharmacological treatments for individuals experiencing perinatal depression.
ja.ma/47YjX3H
💡 This JAMA Insights discusses the most effective pharmacological treatments for individuals experiencing perinatal depression.
ja.ma/47YjX3H
💬 Editorial: #LungCancer screening with low-dose CT is recommended for high-risk adults, but low uptake and restrictive eligibility leave many at risk. Recent policy changes and emerging risk stratification tools may further improve detection.
ja.ma/3JS4Orj
ja.ma/3JS4Orj
November 19, 2025 at 4:20 PM
💬 Editorial: #LungCancer screening with low-dose CT is recommended for high-risk adults, but low uptake and restrictive eligibility leave many at risk. Recent policy changes and emerging risk stratification tools may further improve detection.
ja.ma/3JS4Orj
ja.ma/3JS4Orj
In 2024, only 19% of individuals in the US eligible for annual lung cancer screening underwent screening, preventing an estimated 15 000 deaths. Full uptake could prevent 3 times as many deaths. #LungCancer
ja.ma/48ljLLI
ja.ma/48ljLLI
November 19, 2025 at 4:15 PM
In 2024, only 19% of individuals in the US eligible for annual lung cancer screening underwent screening, preventing an estimated 15 000 deaths. Full uptake could prevent 3 times as many deaths. #LungCancer
ja.ma/48ljLLI
ja.ma/48ljLLI
#AI promises to profoundly change health care, from clinical practice, to training, to research.
JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, highlights 5 key things to consider as these technologies develop.
🔗 Visit JAMA+ AI to learn more: ja.ma/4i3eV9a
JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, highlights 5 key things to consider as these technologies develop.
🔗 Visit JAMA+ AI to learn more: ja.ma/4i3eV9a
November 19, 2025 at 3:00 PM
#AI promises to profoundly change health care, from clinical practice, to training, to research.
JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, highlights 5 key things to consider as these technologies develop.
🔗 Visit JAMA+ AI to learn more: ja.ma/4i3eV9a
JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, highlights 5 key things to consider as these technologies develop.
🔗 Visit JAMA+ AI to learn more: ja.ma/4i3eV9a